|
SYMBICORT(R) (budesonide/formoterol fumarate dihydrate)Long-Term Study Shows …
MarketWatch (press release) More than 22 million Americans are living with asthma, including 2.3+ million African Americans. "These findings provide important information about the use of SYMBICORT in African-American patients with persistent asthma, and may help guide healthcare … AstraZeneca (AZN) Says SYMBICORT Shows Similar Safety Profile to Budesonide in … |
View full post on asthma – Google News